Abstract
The dual-chamber (DC) implantable cardioverter defibrillator (ICD) was primarily introduced in the market to add atrial-based pacing for those patients simultaneously affecting by bradycardia and fatal ventricular arrhythmias. Following the successful introduction of the original VVED ICDs, device capabilities were rapidly expanded by the addition of AV discrimination and atrial anti-tachycardia therapies (DDED ICDs). It was suggested that these sophisticated devices would overcome the limitations of the single chamber (SC) devices and that their recommended use would be extended.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The AVID investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583
Buxton AE, Lee KL, Fisher JD et al (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890
Bardy GH, Lee KL, Mark DB et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237
The DAVID Investigators (2002) The dual chamber and VVI implantable defibrillator (DAVID) trial. Dual chamber pacing or ventricular backup in patients with an implantable defibrillator. JAMA 288:3115–3123
Quesada A, Almendral J, Arribas F et al (2004) The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator. Europace 6:142–150
Bernstein AD, Camm AJ, Fletcher RD et al (1987) The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. Pacing Clin Electrophysiol 10:794–799
Pacífico A, Hohnloser S, Williams J et al (1999) Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 340:1855–1862
Joglar JA, Acusta AP, Shusterman NH et al (2001) Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. Am Heart J 142:498–501
Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Melzer C, Ohm M, Bondke HJ et al (2005) Chronotropic incompetence in patients with an implantable cardioverter defibrillator: prevalence and predicting factors. Pacing Clin Electrophysiol 28:1025–1031
Wolpert C, Jung W, Spehl S et al (2003) Incidence and rate characteristics of atrial tachyarrhythmias in patients with a dual chamber defibrillator. Pacing Clin Electrophysiol 26:1691–1698
Wong CK, White HD, Wilcox RG et al (2000) New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO III experience. Am Heart J 140:878–885
Dries DL, Exner DV, Gersh BJ et al (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32:695–703
Denekea T, Lawoa T, Gerritseb B, Lemkea B for the European GEM DR Investigators (2004) Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation. Europace 6:151–158
Schoels W, Swerdlow CD, Jung W et al (2001) Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. The Worldwide Jewel AF Investigators. J Cardiovasc Electrophysiol 12:521–528
Ricci R, Pignalberi C, Disertori M et al (2002) Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 23:1471
Friedman PA, Dijkman B, Warman EN et al (2001) Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 104:1023–1028
Schwartzman D, Gold M, Quesada A et al for the Worldwide Jewel AF-Only Investigators (2005) Serial evaluation of atrial tachyarrhythmia burden and frequency after implantation of a dual-chamber cardioverter-defibrillator. J Cardiovasc Electrophysiol 16:708–713
Ricci R, Quesada A, Pignalberi C et al (2004) Dual defibrillator improves quality of life and decreases re-hospitalizations in patients with drug refractory atrial fibrillation. J Interventional Card Electrophysiol 10:85–92
Brugada J, Mont L, Figueiredo M et al (1998) Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 9:261–268
Kettering K, Dornberger V, Lang R et al (2001) Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates. Pacing Clin Electrophysiol 24:1325–1333
Deisenhofer I, Kolb Ch, Ndrepepa G et al (2001) Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 12:134–142
Wilkoff B, Gillberg J, De Souza C (2001) The enhanced PR logic dua chamger tachyarrhythmia detection algorithm: retrospective analysis of supraventricular tachycardia with long PR intervals. J Am Coll Cardiol 37(Suppl 2):131A (abs)
Dijkman B, Wellens HJ (2000) Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 11:1309–1319
Stein KM, Euler DE, Mehra R et al (2002) Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? Jewel AF Worldwide Investigators. J Am Coll Cardiol 40:335–340
Al-Khatib S, Lucas F, Jollis J et al (2005) The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 46 1536–1540
Eberhardt F, Bode F, Bonnemeier H et al (2005) Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart 91:500–506
Gregoratos G, Cheitlin MD, Conill A et al (1998) ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary — a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 97:1325–1335
Priori S, Aliot E, Blomstrom-Lundqvist C et al (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22:1374–1450
Friedman PA, McClelland RL, Bamlet WR et al (2006) Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect Supraventricular Tachycardia Study. Circulation 113:2871–2879
Olshansky B, Day JD, Moore S et al (2007) Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation 115:9–16
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this paper
Cite this paper
Quesada, A., Giménez, M., Palanca, V., Jiménez, J., Valle, A., Roda, J. (2007). Which Patients Should Receive Dual Defibrillators? Results of DATAS. In: Gulizia, M.M. (eds) Current News in Cardiology. Springer, Milano. https://doi.org/10.1007/978-88-470-0636-2_32
Download citation
DOI: https://doi.org/10.1007/978-88-470-0636-2_32
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0635-5
Online ISBN: 978-88-470-0636-2
eBook Packages: MedicineMedicine (R0)